INSIDER
US tracking of virus variants has improved after slow start
Read full article: US tracking of virus variants has improved after slow startThe U.S. has improved its surveillance system for tracking new coronavirus variants such as omicron, boosting its capacity by tens of thousands of samples since early this year.
:strip_exif(true):strip_icc(true):no_upscale(true):quality(65)/d1vhqlrjc8h82r.cloudfront.net/12-11-2020/t_fc916e9f18734eb08241128ba054d0f8_name_image.jpg)
FDA advisory panel recommends approval of Pfizer coronavirus vaccine
Read full article: FDA advisory panel recommends approval of Pfizer coronavirus vaccinePfizer has said it will have about 25 million doses of the two-shot vaccine for the U.S. by the end of December. Next week, the FDA will review a second vaccine, from Moderna and the National Institutes of Health, that appears about as protective as Pfizer-BioNTechโs shot. FDA scientists issued a glowing review of the vaccine earlier in the week. The company proposed gradually moving those patients to the vaccine group, with priority based on age, health conditions and other factors. Pfizer must still show whether the vaccine works in children younger than 16 and in pregnant women.